GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...

A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

While Parkinson’s disease (PD ... These investigational agents target key mechanisms implicated in the pathophysiology of PD, ...

A research team led by University of California, Irvine scientists is a step closer to uncovering the mysterious origins of Parkinson’s disease, finding that the incurable disorder appears to take ...

Diagnosed in 2021, Perry Newman, who is originally from Englee, is fundraising to raise enough money to participate in a ...

Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...

The finding emerged during the treatment of two Omani sisters who exhibited rapid disease progression and poor response to ...